Regulatory Story
Go to market news section View chart   Print
RNS
United Drug PLC  -  UDG   

Holding(s) in Company

Released 09:52 02-Jul-2013

RNS Number : 3912I
United Drug PLC
02 July 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi




1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Utd Drug Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):  



3. Full name of person(s) subject to the
notification obligation:
iii

Prudential plc group of companies

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

28 June 2013

6. Date on which issuer notified:

01 July 2013

7. Threshold(s) that is/are crossed or
reached:
vi, vii

13% - 12%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

IE0033024807

31,482,284

31,482,284

31,223,064

31,223,064

0

12.96%

0


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

31,223,064

12.96%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

Prudential plc (parent Company)

M&G Limited (wholly owned subsidiary of M&G Group Limited)

M&G Securities Limited (wholly owned subsidiary of M&G Limited)

M&G Group Limited (wholly owned subsidiary of Prudential plc)

M&G Investment Management Limited (wholly owned subsidiary of M&G Limited)

 

 

 

 


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:


14. Contact name:

James Todd / Mark Thomas

M&G Investment Management Limited

15. Contact telephone number:

020 7548 2293 / 020 7548 3266

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGIGDRBUGBGXD
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Holding(s) in Company - RNS